WST
WST
US9553061055
West Pharmaceutical Services, I
Loading chart...

Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Latest News

Related stocks

MDLN
MDLN • United States
Medline Inc.
36.26 USD
48.79B USD
RMD.AX
RMD.AX • United States
RESMED CDI 10:1 [RMD]
32.58 AUD
32.02B USD 1Y -23.3%
RMD
RMD • United States
ResMed Inc.
230.05 USD
32.35B USD 1Y -19.7%
RGEN
RGEN • United States
Repligen Corporation
173.88 USD
11.04B USD 1Y +8.6%
SOLV
SOLV • United States
Solventum Corporation
87.29 USD
14.86B USD 1Y +19.3%
AVTR
AVTR • United States
Avantor, Inc.
15.67 USD
10.6B USD 1Y +11.9%
COO
COO • United States
The Cooper Companies, Inc.
54.37 USD
10.34B USD 1Y -22.7%
BAX
BAX • United States
Baxter International Inc.
24.35 USD
12.59B USD 1Y +5.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
40.7% p.a.
Max Drawdown (5Y)
-59.6%
Sharpe Ratio (5Y)
-0.12
Beta Factor
1.13
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 46.9 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -59.6% in the extended horizon.
ende